Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas

Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients With Pancreatic Cancer

Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients with Pancreatic Cancer

1. Finding patients with pancreatic cancer (in all stages), before any treatment.
2. Non invasively quantify fatty infiltration of pancreas using, MRI DIXON Scan in pancreatic cancer patient relatively to liver.
3. Measuring cell-free blood DNA in those patients for evaluating the aggressiveness of the disease.
4. Quantify the prognostic significance of pancreatic steatosis in comparison with clinical and pathological prognostic indexes used today.

Inclusion Criteria:

• patients diagnosed with any pancreatic cancer, in any stage, before treatment.
• >18 y.o

Exclusion Criteria:

• claustrophobia
• GFR<30
• patients with non mri compatible devices (e.g. orthopaedic external fixation system)
• After chemotherapy treatment or surgical procedure